<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Endoluminal treatment of <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> has become the preferred option for initial intervention for advanced <z:hpo ids='HP_0002664'>neoplasia</z:hpo> without invasive <z:mp ids='MP_0002038'>carcinoma</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>Data from abstracts presented at Digestive Disease Week 2008 provide greater insight into optimal use of existing techniques and an early look at potential next generation therapies </plain></SENT>
<SENT sid="2" pm="."><plain>Results from the AIM <z:mpath ids='MPATH_589'>Dysplasia</z:mpath> trial describe a larger study with longer post-treatment surveillance highlighting the efficacy and tolerability of radiofrequency ablation, while early results from liquid nitrogen cryotherapy studies suggest a potential to obtain similar eradication results with very high tolerability </plain></SENT>
<SENT sid="3" pm="."><plain>Endoscopic resection, despite its risks, remains a popular option for focal as well as more widespread resection of Barrett's mucosa </plain></SENT>
<SENT sid="4" pm="."><plain>Additional abstracts highlight novel approaches to ablation and resection </plain></SENT>
<SENT sid="5" pm="."><plain>Enhanced imaging techniques and molecular marker analysis also appear to improve treatment outcomes </plain></SENT>
<SENT sid="6" pm="."><plain>However, time and further studies of combined approaches to diagnosis and eradication are necessary to optimize treatment algorithms </plain></SENT>
</text></document>